Comparsion of the biocompatibility dialyzer ; AM69 mebrane(Gambro CO.,LTD) VS. polysulfone mebrane (Asahi medical CO.,LTD).

Comparsion of the biocompatibility dialyzer ; AM69 mebrane(Gambro CO.,LTD) VS. polysulfone mebrane (Asahi medical CO.,LTD). - Comparison of the biocompatibility between AN69 mebrare and polysulfon mebrare.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008822

Enrollment

Registered

2012-09-02

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

Blood data sampling when using PS membrane dialyzer Data sampling after 2 weeks washout period blood dialyzer change stacked

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Maintenance hemodialysis patients. Patients using the PS membrane dialyzer. Patients with blood clotting occurs in the dialyzer and blood circuit. Patients who do not improve after increasing an anti-clotting drug.

Exclusion criteria

Exclusion criteria: Case of minors subject. If it is determined objectively and not be able to give informed consent subjects valid for any reason.

Design outcomes

Primary

Measure	Time frame
White blood count The number of blood platelets Beta-thromboglobulin	—

Countries

Japan

Contacts

Public ContactYuuji takeda

Keneikai sankou hospital Engineer unit

sanko.honbu@earth.ocn.ne.jp075-676-0001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026